-New level of protection for healthcare workers against latex allergies and microbial transmission due to glove breaches-
Brussels, January 28, 2013 --Ansell, a global leader in protection solutions, will showcase various innovative products in hand protection for healthcare professionals at Arab Health 2013, the largest healthcare exhibition in the Middle East (Dubai, January 28th to 31st 2013). At the Ansell booth (Concourse - Booth C258), visitors are invited to discover the latest innovations in hand protection, in particular two new cutting-edge technologies of the surgical glove range GAMMEXâ. “Ansell has a long tradition of taking part in the Arab Health fair” said Peter Dobbelsteijn, Senior Vice President and Regional Director EMEA. “Once more, healthcare workers may discover the latest Ansell innovations and take part in the on-going discussion about safety and health issues related to glove use.”
The GAMMEXâ Non-Latex Accelerator-Free Sensitive glove with SENSOPRENE™ is 30% thinner than standard synthetic surgical gloves and delivers an unprecedented level of sensitivity combined with strength, resistance and advanced allergy protection. The GAMMEX® Powder-Free glove with AMT Antimicrobial Technology is the first solution to protect surgical staff against microbial transmission due to intraoperative glove breaches. Both technologies are proof points of the ongoing commitment of Ansell to develop clinically relevant products in anticipation of healthcare workers’ needs.
GAMMEX Non-Latex Accelerator-Free Sensitive glove with new SENSOPRENE formulation is 30% thinner than standard synthetic surgical gloves, combining superior sensitivity, glove strength and grip with type I and IV allergy prevention. Allergic reactions to latex proteins (type I allergies) and chemical accelerators (type IV allergies) in gloves are a key issue among healthcare workers. While type I allergies make up 17% of glove-related reactions, 33% are chemical allergies. , This is a result of a skin hypersensitivity called contact dermatitis from regular exposure to chemicals used in glove manufacturing. Often, healthcare workers who use gloves that are latex- and accelerator-free have to make compromises in glove thickness and thus sensitivity. Ansell has solved this issue providing unparalleled strength, resistance, grip and allergy protection.
GAMMEX Powder-Free glove with AMT Antimicrobial Technology is the first surgical glove to incorporate its own immune system to further protect surgical healthcare workers against viruses and bacteria in the event of a breach during surgery. 1 in 3 gloves are perforated during surgical procedures, potentially exposing healthcare providers to pathogens such as HIV or Hepatitis C and drug-resistant bacteria. The gloves kill >99% of a hepatitis C virus surrogate as early as 1 minute following exposure and 99% of HIV-1 strain Mn2 as early as 1 minute following exposure (clinical and laboratory tests). GAMMEX Powder-Free with AMT acts like a second skin, with its own immune system to further protect surgical teams against harmful pathogens.
For more information on the GAMMEX Non-Latex Accelerator-Free Sensitive glove with SENSOPRENE, the GAMMEX Powder-Free gloves with AMT Antimicrobial Technology and the complete GAMMEX range, visit www.ansell.eu.
Ansell Media Relations
Liesbeth Lievens, GC – Ansell
Tel: (32) 2 5287400
Ansell Investor Relations
David Graham, I.R. -Ansell
Tel: (613)9270 7215 / (61)4011 407 49
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well being.
With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 11,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well being category worldwide. Ansell operates in four main business segments: Medical Solutions, Industrial Solutions, Specialty Markets and Sexual Wellness.
Information on Ansell and its products can be found at www.ansell.com